Connect with us

CASI

CASI Pharmaceuticals, Inc. (CASI)
   1.74   -0.01(-0.5714%)
TitleNamePayCurrency PayGenderYear BornTitle Since
Chairman & Chief Executive OfficerDr. Wei-Wu He Ph.D.565359USD1965N/A
Vice President of Fin.Ms. Sara B. Capitelli CPAN/AUSDfemale1966N/A
Pres & Principal Financial OfficerDr. Wei Zhang Ph.D.1131244USD1959N/A
Chief Bus. Devel. OfficerDr. James E. Goldschmidt Ph.D.N/AUSDN/AN/A
Vice President & Global ControllerMs. Amanda CuiN/AUSDfemaleN/AN/A
SymbolDateRatingRating ScoreRating Details
CASI8 December, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI7 December, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI6 December, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI5 December, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI2 December, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI1 December, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI30 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI29 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI28 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI25 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI23 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI22 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI21 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI18 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI17 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI16 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI15 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI14 November, 2022A-4Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Buy)
CASI11 November, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI10 November, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI9 November, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI8 November, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI7 November, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI4 November, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI3 November, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI2 November, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI1 November, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI31 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI28 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI27 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI26 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI25 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI21 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI20 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI19 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI18 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI17 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI14 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI13 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI12 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI11 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI10 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI7 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI6 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI5 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI4 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI3 October, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI30 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI29 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI28 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI27 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI26 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI23 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI22 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI21 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI20 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI19 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI16 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI15 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI14 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI13 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI12 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI9 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI8 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI7 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI6 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI2 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI1 September, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI31 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI30 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI29 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI26 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI25 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI24 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI23 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI22 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI19 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI18 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI17 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI16 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI15 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI12 August, 2022B+3Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Sell)
Rating PB: (Buy)
CASI11 August, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI9 August, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI8 August, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI5 August, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI4 August, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI3 August, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI2 August, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI1 August, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI29 July, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI28 July, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI27 July, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI26 July, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI25 July, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI22 July, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI21 July, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI20 July, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI19 July, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CASI18 July, 2022B+4Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HolderSharesDate ReportedChange
DIMENSIONAL FUND ADVISORS LP1150830 September, 2022-1697
IFP ADVISORS, INC930 September, 20229
RENAISSANCE TECHNOLOGIES LLC1040030 September, 202210400
FEDERATED HERMES, INC.101500030 September, 20220
PRUDENTIAL FINANCIAL INC1100030 September, 202211000
TOWER RESEARCH CAPITAL LLC (TRC)218730 September, 2022130
NORTHERN TRUST CORP2559330 September, 2022-4073
VANGUARD GROUP INC25744330 September, 2022-48689
SUSQUEHANNA INTERNATIONAL GROUP, LLP3363730 September, 202233637
ADVISOR GROUP HOLDINGS, INC.20030 September, 20220
BLACKROCK INC.9171430 September, 20220
UBS GROUP AG308930 September, 20223089
WELLINGTON SHIELDS CAPITAL MANAGEMENT, LLC21824730 September, 20224997
WELLINGTON SHIELDS & CO., LLC14531530 September, 2022-2
FRANKLIN RESOURCES INC2454630 September, 2022243
STATE STREET CORP3555530 September, 20220
MORGAN STANLEY379730 September, 20221486
GEODE CAPITAL MANAGEMENT, LLC9830830 September, 2022-16886
BNP PARIBAS ARBITRAGE, SNC13430 September, 2022134
IKARIAN CAPITAL, LLC13201430 June, 2022132014
HolderSharesDate ReportedWeight Percent
DIMENSIONAL FUND ADVISORS LP13209931 March, 2022N/A
BOOTHBAY FUND MANAGEMENT, LLC11686231 March, 2022N/A
Anson Funds Management LP26750731 December, 2021N/A
IDG-Accel China Growth Fund III Associates L.P.797353630 September, 2021N/A
NEW YORK STATE COMMON RETIREMENT FUND51330 June, 2021N/A
Schwab U.S. Broad Market ETF2384431 August, 2020N/A
iShares Russell 2000 Value ETF5690631 August, 2020N/A
iShares Russell 2000 Growth ETF42927331 August, 20200.01
SSgA SPDR Russell 2000 US Small Cap UCITS ETF5388531 August, 20200.01
iShares Russell 3000 ETF1434631 August, 2020N/A
iShares Core S&P Total U.S. Stock Market ETF2155931 August, 2020N/A
Schwab U.S. Small-Cap ETF16961631 August, 2020N/A
iShares Micro-Cap ETF13761931 August, 20200.03
iShares Russell 2000 ETF115731031 August, 2020N/A
Vanguard Total Stock Market Index Fund176255031 August, 2020N/A
EQ/Small Company Index Portfolio2230031 July, 2020N/A
Vanguard Extended Market Index Fund74658731 July, 2020N/A
Fidelity Extended Market Index Fund24289331 July, 2020N/A
EQ/2000 Managed Volatility Portfolio12522631 July, 20200.01
Schwab Small-Cap Index Fund11613331 July, 20200.01
Fidelity Total Market Index Fund7691331 July, 2020N/A
Vanguard Russell 2000 Index Fund6625231 July, 20200.01
Fidelity NASDAQ Composite Index Fund5773331 July, 2020N/A
Vanguard Balanced Index Fund5534131 July, 2020N/A
Vanguard Institutional Total Stock Market Index Fund4738431 July, 2020N/A
ATM Small Cap Managed Volatility Portfolio4043131 July, 20200.01
CREF Stock Account3951831 July, 2020N/A
Vanguard Russell 2000 Growth Index Fund3465431 July, 20200.01
CREF Equity Index Account3383731 July, 2020N/A
TIAA-CREF Equity Index Fund3278231 July, 2020N/A
Fidelity Series Total Market Index Fund3215131 July, 2020N/A
EQ/AB Small Cap Growth Portfolio2940031 July, 2020N/A
VALIC Co I Small Cap Index Fund2631631 July, 20200.01
Xtrackers Russell 2000 UCITS ETF2551931 July, 20200.01
Schwab Total Stock Market Index Fund2521531 July, 2020N/A
Pacific Select Small-Cap Index Portfolio2055631 July, 20200.01
John Hancock VIT - Small Cap Index1646331 July, 20200.01
Vanguard US Equity Index Fund1538731 July, 2020N/A
1290 VT Micro Cap Portfolio1245231 July, 20200.02
EQ/Morgan Stanley Small Cap Growth Portfolio1048531 July, 2020N/A
Mirovye rynki OPIFA2395430 June, 20202.05
American Beacon Zebra Small Cap Equity Fund3947630 June, 20200.15
Northern Small Cap Core Fund3826930 June, 20200.03
Bridgeway Small Cap Value Fund20520030 June, 20201.71
Voya VP Russell Small Cap Index Port2101030 June, 20200.01
Northern Small Cap Index Fund2950930 June, 20200.01
T. Rowe Price Extended Equity Market Index Fund2450030 June, 20200.01
TIAA-CREF Small Cap Blend Index Fund7201930 June, 20200.01
Fidelity Small Cap Index Fund29203930 April, 20200.01
Bridge Builder Small/Mid Cap Growth Fund1862231 March, 2020N/A
iShares Russell 2000 Small-Cap Index Fund7490031 March, 20200.01
Florida State Board Administration Fund1332831 March, 2020N/A
New Covenant Growth Fund1587431 March, 20200.01
Invesco Wilshire Micro-Cap ETF1050831 January, 2019N/A
SymbolTransaction DateReporting CikSecurities OwnedCompany CikReporting NameAcquistion Or DispositionForm TypeSecurities TransactedSecurity NameLink
CASI8 September, 202200015731603715170000895051Huang JamesA433300Common StockView
CASI7 September, 2022000156978230000000895051Zukiwski Alexander AA43000Employee Stock Option (Right to Buy)View
CASI7 September, 202200015731603382170000895051Huang JamesA43111Common StockView
CASI6 September, 202200015731603351060000895051Huang JamesA419162Common StockView
CASI2 September, 202200015731603159440000895051Huang JamesA4400Common StockView
CASI1 September, 202200015731603155440000895051Huang JamesA411821Common StockView
CASI31 August, 202200015731603037230000895051Huang JamesA424975Common StockView
CASI26 August, 202200015731602787480000895051Huang JamesA439527Common StockView
CASI24 August, 202200015731602392210000895051Huang JamesA45000Common StockView
CASI23 August, 202200015731602342210000895051Huang JamesA440000Common StockView
CASI22 August, 202200015731601942210000895051Huang JamesA423105Common StockView
CASI19 August, 202200015731601711160000895051Huang JamesA4171116Common StockView
CASI15 June, 202200015420736445530000895051He Wei-WuA450000Common StockView
CASI14 June, 202200015420735945530000895051He Wei-WuA42096Common StockView
CASI13 June, 202200015420735924570000895051He Wei-WuA436058Common StockView
CASI25 May, 202200016086273883870000895051Salisbury Franklin Cary jrA4388387Stock Option (Right to Buy)View
CASI25 May, 202200014915033806450000895051Zhou QuanA4380645Stock Option (Right to Buy)View
CASI25 May, 202200015731603974190000895051Huang JamesA4397419Stock Option (Right to Buy)View
CASI25 May, 202200011939183458060000895051SHROTRIYA RAJESH C MDA4345806Stock Option (Right to Buy)View
CASI25 May, 202200016824193883870000895051Wu Yue AlexanderA4388387Stock Option (Right to Buy)View
CASI2 December, 202100015697825000000000895051Zukiwski Alexander AD4500000Employee Stock Option (Right to Buy)View
CASI18 November, 2021000154207355584720000895051He Wei-WuA4200000Common StockView
CASI17 November, 2021000154207353625690000895051He Wei-WuA4200000Common StockView
CASI19 August, 2021000154207351639940000895051He Wei-WuA4180000Common StockView
CASI18 August, 2021000154207349839940000895051He Wei-WuA4300000Common StockView
CASI24 July, 202100017549038000000000895051Zhang LarryD4800000Employee Stock Option (Right to Buy)View
CASI15 June, 202100016086271104590000895051Salisbury Franklin Cary jrA4110459Stock Option (Right to Buy)View
CASI15 June, 202100016824191104590000895051Wu Yue AlexanderA4110459Stock Option (Right to Buy)View
CASI15 June, 20210001193918983490000895051SHROTRIYA RAJESH C MDA498.349Stock Option (Right to Buy)View
CASI15 June, 202100014915031082570000895051Zhou QuanA4108257Stock Option (Right to Buy)View
CASI15 June, 202100015731601130280000895051Huang JamesA4113028Stock Option (Right to Buy)View
CASI15 June, 2021000154207340000000000895051He Wei-WuA44000000Stock Options (Right to Buy)View
CASI26 March, 2021000154207330000000000895051He Wei-WuA43000000Common StockView
CASI22 December, 2020000154207346839940000895051He Wei-WuD4380000Common StockView
CASI17 December, 2020000183536877210000895051Xu WeihaoA41721Common StockView
CASI17 December, 20200001835368100000000895051Xu WeihaoA42279Common StockView
CASI16 December, 2020000183536860000000895051Xu WeihaoA42000Common StockView
CASI16 December, 202000018353688000000000895051Xu WeihaoA4800000Employee Stock Option (Right to Buy)View
CASI23 November, 2020000154207350639940000895051He Wei-WuA4100000Common StockView
CASI20 November, 2020000154207349639940000895051He Wei-WuA4127471Common StockView
CASI22 July, 20200001754903201530000895051Zhang LarryA420153Common StockView
CASI22 July, 2020000154207348365230000895051He Wei-WuA42952426Common StockView
CASI22 July, 2020000154207375323470000895051He Wei-WuA41200000Common StockView
CASI16 June, 20200001608627688000000895051Salisbury Franklin Cary jrA468800Stock Option (Right to Buy)View
CASI16 June, 20200001682419688000000895051Wu Yue AlexanderA468800Stock Option (Right to Buy)View
CASI16 June, 20200001573160704000000895051Huang JamesA470400Stock Option (Right to Buy)View
CASI16 June, 20200001491503674290000895051Zhou QuanA467429Stock Option (Right to Buy)View
CASI16 June, 20200001193918612570000895051SHROTRIYA RAJESH C MDA461257Stock Option (Right to Buy)View
CASI20 May, 2020000154207318840970000895051He Wei-WuA456464Common StockView
CASI19 May, 2020000154207318276630000895051He Wei-WuA429801Common StockView
CASI18 May, 2020000154207317978320000895051He Wei-WuA4338932Common StockView
CASI15 May, 2020000154207314589000000895051He Wei-WuA4100000Common StockView
CASI27 March, 2020000154207313589000000895051He Wei-WuA46880Common StockView
CASI26 March, 2020000154207313520200000895051He Wei-WuA4328095Common StockView
CASI25 March, 2020000154207310239250000895051He Wei-WuA4196398Common StockView
CASI19 March, 2020000154207363323470000895051He Wei-WuA4234488Common StockView
CASI18 March, 2020000154207360978590000895051He Wei-WuA4501322Common StockView
CASI17 March, 2020000154207355965370000895051He Wei-WuA4264192Common StockView
CASI30 December, 2019000172354400000895051Wealth Strategy Holding LtdD4493827WarrantView
CASI30 December, 2019000172354490878880000895051Wealth Strategy Holding LtdA4493827Common StockView
CASI16 December, 2019000154207353323450000895051He Wei-WuA4374321Common StockView
CASI16 December, 2019000154207300000895051He Wei-WuD4374321WarrantView
CASI15 December, 201900015697822000000000895051Zukiwski Alexander AD4200000Employee Stock Option (Right to Buy)View
CASI20 September, 201900017549032000000000895051Zhang LarryD4200000Employee Stock Option (Right to Buy)View
CASI16 August, 201900015420738275270000895051He Wei-WuA420000Common StockView
CASI14 August, 201900015420738075270000895051He Wei-WuA4160000Common StockView
CASI20 June, 20190001608627578850000895051Salisbury Franklin Cary jrA457885Stock Option (Right to Buy)View
CASI20 June, 20190001193918515380000895051SHROTRIYA RAJESH C MDA451538Stock Option (Right to Buy)View
CASI20 June, 20190001682419578850000895051Wu Yue AlexanderA457885Stock Option (Right to Buy)View
CASI20 June, 20190001491503567310000895051Zhou QuanA456731Stock Option (Right to Buy)View
CASI20 June, 2019000154207340000000000895051He Wei-WuA44000000Stock Option (Right to Buy)View
CASI20 June, 20190001573160592310000895051Huang JamesA459231Stock Option (Right to Buy)View
CASI20 June, 20190001545181515380000895051Ren Ken KeyongA451538Stock Option (Right to Buy)View
CASI2 April, 2019000083154753974130000895051SPECTRUM PHARMACEUTICALS INCD41500000Common StockView
CASI29 January, 20190001545181750000000895051Ren Ken KeyongA475000Stock Options (Right to Buy)View
CASI29 January, 20190001364709750000000895051Hu Cynthia W.A475000Stock Options (Right to Buy)View
CASI14 January, 2019000136470900000895051Hu Cynthia W.D415000Employee Stock Option (Right to Buy)View
CASI14 January, 20190001364709327850000895051Hu Cynthia W.A415000Common StockView
CASI14 January, 20190001364709296850000895051Hu Cynthia W.D43100Common StockView
CASI19 December, 201800015420736475270000895051He Wei-WuD4200000Common StockView
CASI3 December, 201800015451817200000000895051Ren Ken KeyongA4720000Stock Options (Right to Buy)View
CASI13 November, 2018000166383100000895051SPARKLE BYTE LTDD4948982WarrantView
CASI13 November, 20180001663831101985180000895051SPARKLE BYTE LTDA41699753Common StockView
CASI28 September, 201800017534344000000000895051Chi GeorgeA4400000Stock Options (Right to Buy)View
CASI12 July, 20180001509032266000000895051CAPITELLI SARA BD48400Common StockView
CASI12 July, 2018000150903200000895051CAPITELLI SARA BD426600Common StockView
CASI12 July, 2018000150903200000895051CAPITELLI SARA BD435000Employee Stock Option (Right to Buy)View
CASI12 July, 20180001509032350000000895051CAPITELLI SARA BA435000Common StockView
CASI29 June, 20180001570852350000000895051Wu AlexA435000Stock Options (Right to Buy)View
CASI29 June, 20180001608627350000000895051Salisbury Franklin Cary jrA435000Stock Options (Right to Buy)View
CASI29 June, 20180001193918350000000895051SHROTRIYA RAJESH C MDA435000Stock Options (Right to Buy)View
CASI29 June, 20180001491503500000000895051Zhou QuanA450000Stock Options (Right to Buy)View
CASI29 June, 20180001573160500000000895051Huang JamesA450000Stock Options (Right to Buy)View
CASI11 June, 2018000154207310000000000895051He Wei-WuA41000000Stock Options (Right to Buy)View
CASI12 April, 20180001509032269780000895051CAPITELLI SARA BA426978Common StockView
CASI12 April, 20180001509032187780000895051CAPITELLI SARA BD48200Common StockView
CASI12 April, 2018000150903200000895051CAPITELLI SARA BD418778Common StockView
CASI12 April, 2018000150903200000895051CAPITELLI SARA BD426978Employee Stock Option (Right to Buy)View
CASI4 April, 2018000157316000000895051Huang JamesD4416666Common StockView
CASI4 April, 201800015731601910000895051Huang JamesA4191Common StockView
SymbolDatePeriodDownload XLSX File
CASI2021FYDownload XLSX File
CASI2020FYDownload XLSX File
CASI2019FYDownload XLSX File
CASI2018FYDownload XLSX File
CASI2017FYDownload XLSX File
CASI2016FYDownload XLSX File
CASI2015FYDownload XLSX File
CASI2014FYDownload XLSX File
CASI2013FYDownload XLSX File
CASI2012FYDownload XLSX File
CASI2011FYDownload XLSX File
CASI2022Q3Download XLSX File
CASI2022Q2Download XLSX File
CASI2022Q1Download XLSX File
CASI2021Q3Download XLSX File
CASI2021Q4Download XLSX File
CASI2021Q2Download XLSX File
CASI2021Q1Download XLSX File
CASI2020Q4Download XLSX File
CASI2020Q3Download XLSX File
CASI2020Q2Download XLSX File
CASI2020Q1Download XLSX File
CASI2019Q4Download XLSX File
CASI2019Q3Download XLSX File
CASI2019Q2Download XLSX File
CASI2019Q1Download XLSX File
CASI2018Q4Download XLSX File
CASI2018Q3Download XLSX File
CASI2018Q2Download XLSX File
CASI2018Q1Download XLSX File
CASI2017Q4Download XLSX File
CASI2017Q3Download XLSX File
CASI2017Q2Download XLSX File
CASI2017Q1Download XLSX File
CASI2016Q4Download XLSX File
CASI2016Q1Download XLSX File
CASI2016Q2Download XLSX File
CASI2016Q3Download XLSX File
CASI2015Q4Download XLSX File
CASI2015Q3Download XLSX File
CASI2015Q2Download XLSX File
CASI2015Q1Download XLSX File
CASI2014Q4Download XLSX File
CASI2014Q3Download XLSX File
CASI2014Q2Download XLSX File
CASI2014Q1Download XLSX File
CASI2013Q4Download XLSX File
CASI2013Q3Download XLSX File
CASI2013Q2Download XLSX File
CASI2013Q1Download XLSX File
CASI2012Q4Download XLSX File
CASI2012Q3Download XLSX File
CASI2012Q2Download XLSX File
CASI2012Q1Download XLSX File
CASI2011Q4Download XLSX File
CASI2011Q3Download XLSX File
CASI2011Q2Download XLSX File

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
14 November, 2022CASI-0.38-0.38bmo102130000
12 August, 2022CASI-0.56-0.56bmo85730000
12 May, 2022CASI-0.06-0.06bmo906200012082666
28 March, 2022CASI-0.04-0.04bmo91580009000000
12 November, 2021CASI-0.07-0.07bmo81120008400000
12 August, 2021CASI-0.05-0.05bmo71620007162000
13 May, 2021CASI-0.11-0.11bmo57360005323725
10 August, 2020CASI-0.09-0.09amc26710002374222.2222222
11 May, 2020CASI-0.09-0.09bmo34060004162888.8888889
16 March, 2020CASI-0.12-0.12bmo13440001232000
12 November, 2019CASI-0.1-0.1bmo27870003065700
9 August, 2019CASI-0.16-0.16bmo00
15 May, 2019CASI-0.09-0.09bmo00
29 March, 2019CASI-0.1-0.1bmo00
14 November, 2018CASIbmo00
14 August, 2018CASI-0.07-0.07bmo00
15 May, 2018CASI-0.05-0.05bmo00
29 March, 2018CASI-0.08-0.08bmo00
14 November, 2017CASI-0.03-0.03bmo00
14 August, 2017CASIbmo00
15 May, 2017CASIbmo00
31 March, 2017CASI-0.05-0.05bmo00
14 November, 2016CASI-0.03-0.03bmo00
15 August, 2016CASI-0.08-0.08bmo00
13 May, 2016CASI-0.04-0.04bmo00
28 March, 2016CASI-0.05-0.05bmo028627.2
13 November, 2015CASI-0.05-0.05bmo066796.8
14 August, 2015CASI-0.06-0.06bmo2399420000
15 May, 2015CASIbmo237180
27 March, 2015CASIbmo237270
14 November, 2014CASIbmo00
14 August, 2014CASIbmo00
6 November, 2008CASI-0.44-0.44bmo35013074375000
2 May, 2008CASI-1.1-1.1bmo00
6 March, 2008CASI-0.55-0.55bmo38753923104000
6 November, 2007CASI-0.44-0.44bmo35202596160000
8 August, 2007CASI-1.1-1.1bmo00
9 May, 2007CASI-0.99-0.99bmo00
13 March, 2007CASI-0.88-0.88bmo38711732902500
6 November, 2006CASI-0.55-0.55bmo30231854832000
9 August, 2006CASI-0.99-0.99bmo00
10 May, 2006CASI-5.83-5.83bmo00
7 March, 2006CASI-0.55-0.55bmo40637452442000
3 November, 2005CASI-0.99-0.99bmo1249600927828
28 July, 2005CASI-0.99-0.99bmo579461837777.77777778
3 May, 2005CASI-1.43-1.43bmo2524927692.307692308
9 March, 2005CASI-0.22-0.22bmo133911195000
3 August, 2004CASI-1.32-1.32bmo139380175000
27 April, 2004CASI-1.54-1.54bmo9796792857.142857143
20 February, 2004CASI-1.98-1.98bmo517533346666.66666667
6 November, 2003CASI-1.65-1.65bmo258478260000
4 March, 2003CASI-0.77-0.77bmo4618211380000
14 November, 2002CASI-5.94-5.94bmo345569321111.11111111
14 August, 2002CASI-5.61-5.61bmo309170379435
15 May, 2002CASI-7.37-7.37bmo5993061203
5 March, 2002CASI-14.19-14.19bmo1294780
7 November, 2001CASI3.633.63bmo90988203732
9 August, 2001CASI-9.02-9.02bmo757523519002
10 May, 2001CASI-6.82-6.82bmo8839521000912
30 March, 2001CASI-9.02-9.02bmo12239650
31 October, 2000CASI-7.26-7.26bmo854170956670
9 August, 2000CASI-9.24-9.24bmo866941654295
10 May, 2000CASI-7.92-7.92bmo726699726699
22 March, 2000CASI-11.11-11.11bmo4000000
12 November, 1999CASI-5.28-5.28bmo18000002084210
11 August, 1999CASI-6.71-6.71bmo13000001070722.125
24 May, 1999CASI-6.05-6.05bmo14000001386444.09375
1 March, 1999CASI-3.85-3.85bmo15000000
27 October, 1998CASI-3.41-3.41bmo13000001049999
10 August, 1998CASI-1.65-1.65bmo12000001598380
18 May, 1998CASI-2.75-2.75bmo12000001095652
31 March, 1998CASI-1.87-1.87bmo12000000
13 November, 1997CASI-1.65-1.65bmo12000001452631
18 August, 1997CASI-1.1-1.1bmo11000001430000
13 May, 1997CASI-1.32-1.32bmo11000001423529
24 March, 1997CASI-1.1-1.1bmo11000000
18 November, 1996CASI-1.21-1.21bmo11000001406842

Company Profile

Company Name CASI Pharmaceuticals, Inc.
Symbol CASI
Currency USD
Price 1.74
Exchange Name NASDAQ Capital Market (NASDAQ)
Industry Biotechnology
CEO Dr. Wei-Wu He
Sector Healthcare
Country US
Full Time Employees 176
Phone 12408642600
Address 9620 Medical Center Dr Ste 300
City Rockville
State MARYLAND
Zip 20850
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma (B-NHL); BI-1206 that is in Phase I/II trial in combination with anti-PD1 therapy Keytruda for solid tumors, and in a Phase I/IIa trial in combination with MabThera (rituximab) in patients with relapsed/refractory NHL; and CB-5339, which is in Phase I clinical trial for acute myeloid leukemia and myelodysplastic syndrome. Its product pipeline also comprises CID-103 for the treatment of patients with multiple myeloma; Thiotepa, which has multiple indications including use as a conditioning treatment for various allogeneic haemopoietic stem cell transplants; and Octreotide long acting injectable formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumors. The company has licensing agreements with Juventas Cell Therapy Ltd; BioInvent International AB; Black Belt Therapeutics Limited; and Cleave Therapeutics, Inc. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co., Ltd; Pharmathen Global BV; and Riemser Pharma GmbH. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Rockville, Maryland.
Click to comment

More in

>

FREE

Get the most important news and analyses for Free.

Thank you for subscribing.

Something went wrong.